Skip to main content
SpringerLink
Log in

Rivaroxaban bei Patienten mit akutem Koronarsyndrom

ATLAS ACS 2-TIMI 51

Rivarobaxan for patients with recent acute coronary syndrome

ATLAS ACS 2-TIMI 51

  • Klinische Studien
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Roe MT, Ohman EM (2012) A new era in secondary prevention after acute coronary syndrome. N Engl J Med 366:85–87

    Google Scholar 

  2. Alexander JH, Lopes RD, James S et al (2011) Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med 365:699–708

    Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist für sich und seine Koautorin auf folgende Beziehungen hin: Referententätigkeit Bayer, Boehringer Ingelheim (N. Frey).

Author information

Authors and Affiliations

  1. Klinik für Kardiologie und Angiologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Schittenhelmstr. 12, 24105, Kiel, Deutschland

    N. Frey

  2. Werl-Westönnen, Deutschland

    S. Nitschmann

Authors
  1. N. Frey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Nitschmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. Frey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frey, N., Nitschmann, S. Rivaroxaban bei Patienten mit akutem Koronarsyndrom. Internist 54, 118–120 (2013). https://doi.org/10.1007/s00108-012-3205-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-012-3205-4

Search

Navigation